ROBERT JOSEPH MANGIALARDI

Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease NASHVILLE, TN NPI 1477548675

General Payments — all program years on this page

$4,210.79

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 233
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $445.49 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $445.4919

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $744.8655
2019 $656.8236
2020 $410.8024
2021 $386.3323
2022 $775.7342
2023 $790.7634
2024 $445.4919

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078914601 Actelion Pharmaceuticals US, Inc. $19.05 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078914609 Actelion Pharmaceuticals US, Inc. $88.31 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078914709 Actelion Pharmaceuticals US, Inc. $34.38 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078914725 Actelion Pharmaceuticals US, Inc. $24.37 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078914743 Actelion Pharmaceuticals US, Inc. $19.16 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089577906 Insmed, Inc. $24.63 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114107261 Regeneron Healthcare Solutions, Inc. $19.86 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114107263 Regeneron Healthcare Solutions, Inc. $22.39 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116099849 GlaxoSmithKline, LLC. $15.56 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116348596 GlaxoSmithKline, LLC. $15.39 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116372321 GlaxoSmithKline, LLC. $20.50 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116376666 GlaxoSmithKline, LLC. $8.19 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116506214 GlaxoSmithKline, LLC. $16.47 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116583151 GlaxoSmithKline, LLC. $17.91 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116586635 GlaxoSmithKline, LLC. $18.70 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116721819 GlaxoSmithKline, LLC. $25.02 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116728676 GlaxoSmithKline, LLC. $14.43 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139568347 GENZYME CORPORATION $24.89 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139568367 GENZYME CORPORATION $16.28 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.